This archive contains the following articles listed by volume, issue and page number:
 |
|
|
Volume 16, 2012 Articles |
Title (Click for Details) |
Vol/Issue |
Page |
PreScription: Fifteen Years and Counting |
Vol. 16 No. 1 |
4 |
PreScription: The International Academy of Compounding Pharmacists Remembers Evelyn Timmons, RPh, FIACP, and George Roentsch, RPh, FIACP |
Vol. 16 No. 1 |
4 |
Misinterpretation of United States Pharmacopeia Chapter <797> |
Vol. 16 No. 1 |
6 |
Glutaraldehyde-treated Autologous Pericardium Used in Valve Repairs |
Vol. 16 No. 1 |
12 |
Vitamins: Therapy or Hype |
Vol. 16 No. 1 |
17 |
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management |
Vol. 16 No. 1 |
22 |
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension |
Vol. 16 No. 1 |
34 |
Case Studies of Compounded Tramadol Use in Cats |
Vol. 16 No. 1 |
44 |
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 16 No. 1 |
50 |
Institute for Safe Medication Practices Lifetime Achievement Award 2011 |
Vol. 16 No. 1 |
54 |
The ps in Therapeutics |
Vol. 16 No. 1 |
58 |
The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs |
Vol. 16 No. 1 |
62 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding–Nonsterile Preparations, Part 4 |
Vol. 16 No. 1 |
64 |
Calculations |
Vol. 16 No. 1 |
69 |
Calcium Chloride 10% Injection |
Vol. 16 No. 1 |
70 |
Calcium Gluconate 10% Injection |
Vol. 16 No. 1 |
71 |
Magnesium Sulfate 10% Injection (0.8 mEq/mL) |
Vol. 16 No. 1 |
72 |
Potassium Acetate 2-mEq/mL and 4-mEq/mL Injections |
Vol. 16 No. 1 |
73 |
Potassium Phosphates Injection |
Vol. 16 No. 1 |
74 |
Sodium Acetate 2-mEq/mL and 4-mEq/mL Injections |
Vol. 16 No. 1 |
75 |
Sodium Bicarbonate 4.2%, 5.0%, 7.5%, and 8.4% Injections |
Vol. 16 No. 1 |
76 |
Sodium Chloride 14.6% and 23.4% Injections |
Vol. 16 No. 1 |
77 |
Sodium Phosphates Injection |
Vol. 16 No. 1 |
78 |
Zinc 1-mg/mL and 5-mg/mL Injections |
Vol. 16 No. 1 |
79 |
Chemical Stability of Pentoxifylline in a Topical Cream |
Vol. 16 No. 1 |
80 |
Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration |
Vol. 16 No. 1 |
82 |
PostScription: Best Practice Recommendations for Compounding 17-Hydroxyprogesterone |
Vol. 16 No. 1 |
86 |
PreScription: Support the Organizations that Support You and Your Practice |
Vol. 16 No. 2 |
92 |
PreScription: Pharmacy Compounding Accreditation Board: A Banner Year, More to Come |
Vol. 16 No. 2 |
92 |
The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy |
Vol. 16 No. 2 |
94 |
Brazilian National System for the Monitoring and Improvement of Compounding Practices: Program Outcomes |
Vol. 16 No. 2 |
98 |
Development of a Standardized Intranet Database of Formulation Records for Nonsterile Compounding, Part 2 |
Vol. 16 No. 2 |
104 |
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy |
Vol. 16 No. 2 |
110 |
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum |
Vol. 16 No. 2 |
117 |
A Concise Discussion of Headache Types, Part 1 |
Vol. 16 No. 2 |
125 |
Trade Shows: Planning Your Strategy |
Vol. 16 No. 2 |
134 |
Quality Control: 5 Steps to Improve Quality in the Compounding Lab |
Vol. 16 No. 2 |
136 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1 |
Vol. 16 No. 2 |
146 |
Calculations |
Vol. 16 No. 2 |
152 |
Amiodarone Hydrochloride 50-mg/mL Injection |
Vol. 16 No. 2 |
154 |
Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection |
Vol. 16 No. 2 |
155 |
Caffeine Citrate 20-mg/mL Injection |
Vol. 16 No. 2 |
156 |
Chromium 4-mcg/mL Injection |
Vol. 16 No. 2 |
157 |
Furosemide 10-mg/mL Injection |
Vol. 16 No. 2 |
158 |
Glycopyrrolate 0.2-mg/mL Injection |
Vol. 16 No. 2 |
159 |
Labetalol Hydrochloride 5-mg/mL Injection |
Vol. 16 No. 2 |
160 |
Lorazepam 4-mg/mL Injection |
Vol. 16 No. 2 |
161 |
Midazolam 5-mg/mL Injection |
Vol. 16 No. 2 |
162 |
Promethazine Hydrochloride 50-mg/mL Injection |
Vol. 16 No. 2 |
163 |
Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) |
Vol. 16 No. 2 |
164 |
Stability of Vancomycin in SyrSpend SF |
Vol. 16 No. 2 |
167 |
Stability of Acetyl-L-carnitine in 5% Dextrose Using a High-Performance Liquid Chromatography–Mass Spectrometry Times 2 Method |
Vol. 16 No. 2 |
170 |
PostScription: The Importance of Science in the Pharmacy Curriculum |
Vol. 16 No. 2 |
174 |
PreScription: You're On Your Own |
Vol. 16 No. 3 |
180 |
PreScription: Working in Handcuffs |
Vol. 16 No. 3 |
180 |
A Concise Discussion of Headache Types, Part 2: Migraine |
Vol. 16 No. 3 |
182 |
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease |
Vol. 16 No. 3 |
190 |
Burning Mouth Syndrome: A Discussion of a Complex Pathology |
Vol. 16 No. 3 |
196 |
The Student Pharmacist Compounding Competition: Creating Problem Solvers |
Vol. 16 No. 3 |
206 |
Treatment and Prevention of Insect Bites: Mosquitoes |
Vol. 16 No. 3 |
210 |
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 16 No. 3 |
220 |
Marketing: 16 Ways to Incorporate Facebook into Your Compounding Pharmacy |
Vol. 16 No. 3 |
224 |
Quality Control: Analytical Methods: Why Do I Need a Certificate of Analysis? |
Vol. 16 No. 3 |
226 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification |
Vol. 16 No. 3 |
230 |
Calculations |
Vol. 16 No. 3 |
236 |
Acetazolamide 100-mg/mL Injection |
Vol. 16 No. 3 |
238 |
Alfentanil 500-mcg/mL Injection |
Vol. 16 No. 3 |
239 |
Ascorbic Acid 250-mg/mL Injection |
Vol. 16 No. 3 |
240 |
Diltiazem Hydrochloride 5-mg/mL Injection |
Vol. 16 No. 3 |
241 |
Famotidine 10-mg/mL Injection |
Vol. 16 No. 3 |
242 |
Metoclopramide 5-mg/mL Injection |
Vol. 16 No. 3 |
243 |
Naloxone Hydrochloride 1-mg/mL Injection |
Vol. 16 No. 3 |
244 |
Orphenadrine Citrate 30-mg/mL Injection |
Vol. 16 No. 3 |
245 |
Prochlorperazine 5-mg/mL Injection |
Vol. 16 No. 3 |
246 |
Ranitidine 25-mg/mL Injection |
Vol. 16 No. 3 |
247 |
In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream |
Vol. 16 No. 3 |
248 |
Compounding and Dispensing Errors Before and After Implementing Barcode Technology in a Nuclear Pharmacy |
Vol. 16 No. 3 |
253 |
Influence of Temperature on the Thirty-Day Chemical Stability of Extemporaneously Prepared Dexamethasone Paste |
Vol. 16 No. 3 |
258 |
PostScription: Rules for Pharmaceutically Elegant Calculations |
Vol. 16 No. 3 |
262 |
PreScription: Lifelong Learning |
Vol. 16 No. 4 |
268 |
PreScription: Drug Shortages and Discontinued Drugs |
Vol. 16 No. 4 |
268 |
A Concise Discussion of Headache Types, Part 3: Migraine |
Vol. 16 No. 4 |
270 |
Compounding Prokinetic Medications for Companion Animals |
Vol. 16 No. 4 |
276 |
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide |
Vol. 16 No. 4 |
288 |
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers |
Vol. 16 No. 4 |
294 |
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 16 No. 4 |
300 |
Selection of Color Additives: A Regulatory View |
Vol. 16 No. 4 |
304 |
Okay, I've Got It: Now What Do I Do With It? |
Vol. 16 No. 4 |
310 |
Quality Control: Glassware Washers: Cleaning Glassware and Implements Used in Compounding, Part 1 |
Vol. 16 No. 4 |
312 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing |
Vol. 16 No. 4 |
322 |
Calculations |
Vol. 16 No. 4 |
330 |
Betamethasone 0.6-mg/5-mL Syrup |
Vol. 16 No. 4 |
332 |
Butorphanol Tartrate 2-mg/mL Injection |
Vol. 16 No. 4 |
333 |
Diphenhydramine Hydrochloride 50-mg/mL Injection |
Vol. 16 No. 4 |
334 |
Etomidate 2-mg/mL Injection |
Vol. 16 No. 4 |
335 |
Foscarnet Sodium 24-mg/mL Injection |
Vol. 16 No. 4 |
336 |
Ketorolac Tromethamine 15-mg/mL Injection |
Vol. 16 No. 4 |
337 |
Methyldopate Hydrochloride 50-mg/mL Injection |
Vol. 16 No. 4 |
338 |
Ondansetron Hydrochloride 2-mg/mL Injection |
Vol. 16 No. 4 |
339 |
Sufentanil Citrate 50-mcg/mL Injection |
Vol. 16 No. 4 |
340 |
Tobramycin 40-mg/mL Injection |
Vol. 16 No. 4 |
341 |
Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets |
Vol. 16 No. 4 |
342 |
Stability of Gabapentin in SyrSpend SF |
Vol. 16 No. 4 |
347 |
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare |
Vol. 16 No. 4 |
350 |
PreScription: What Is Involved in the Making of Remington's? |
Vol. 16 No. 5 |
356 |
Remington: The Science and Practice of Pharmacy: From the Past into the Future |
Vol. 16 No. 5 |
358 |
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report |
Vol. 16 No. 5 |
364 |
Medical Therapy for Acquired Urinary Incontinence in Dogs |
Vol. 16 No. 5 |
369 |
Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol |
Vol. 16 No. 5 |
376 |
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 16 No. 5 |
382 |
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies |
Vol. 16 No. 5 |
386 |
Marketing: Drug Shortages and Discontinued Drugs: Marketing Techniques that Compounding Pharmacists Can Use to Advise and Serve Their Patients |
Vol. 16 No. 5 |
394 |
Quality Control: Glassware Washers: Cleaning Glassware and Implements Used in Compounding, Part 2 |
Vol. 16 No. 5 |
396 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 4: Cleaning and Packaging |
Vol. 16 No. 5 |
405 |
Calculations |
Vol. 16 No. 5 |
416 |
Doxapram Hydrochloride 20-mg/mL injection |
Vol. 16 No. 5 |
418 |
Enalaprilat 1.25-mg/mL Injection |
Vol. 16 No. 5 |
419 |
Esmolol Hydrochloride 10-mg/mL Injection |
Vol. 16 No. 5 |
420 |
Fluconazole 2-mg/mL Injection |
Vol. 16 No. 5 |
421 |
Haloperidol 50-mg/mL in Oil Injection |
Vol. 16 No. 5 |
422 |
Meperidine Hydrochloride 50-mg/mL Injection |
Vol. 16 No. 5 |
423 |
Methocarbamol 100-mg/mL Injection |
Vol. 16 No. 5 |
424 |
Metronidazole 5-mg/mL Injection |
Vol. 16 No. 5 |
425 |
Nalbuphine Hydrochloride 10-mg/mL Injection |
Vol. 16 No. 5 |
426 |
Oxymorphone Hydrochloride 1-mg/mL Injection |
Vol. 16 No. 5 |
427 |
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date |
Vol. 16 No. 5 |
428 |
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time |
Vol. 16 No. 5 |
431 |
Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization |
Vol. 16 No. 5 |
434 |
PostScription: Remington Twenty-Second Edition |
Vol. 16 No. 5 |
438 |
PreScription: A Degree in Pharmacy: How Valuable! |
Vol. 16 No. 6 |
444 |
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act |
Vol. 16 No. 6 |
446 |
Palliative Care and Compounding for Household Pets |
Vol. 16 No. 6 |
452 |
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis |
Vol. 16 No. 6 |
456 |
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents |
Vol. 16 No. 6 |
462 |
Beyond-use Date: Establishment and Maintenance |
Vol. 16 No. 6 |
471 |
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists |
Vol. 16 No. 6 |
476 |
Colds and Cough |
Vol. 16 No. 6 |
480 |
Marketing: Overcoming Objections to Prescribing Compounded Medications |
Vol. 16 No. 6 |
484 |
Quality Control: Analytical Methods. Certificates of Analysis, Part 1 |
Vol. 16 No. 6 |
486 |
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel |
Vol. 16 No. 6 |
490 |
Calculations |
Vol. 16 No. 6 |
498 |
Aminophylline 25-mg/mL Injection |
Vol. 16 No. 6 |
500 |
Ammonium Chloride 5-mEq/mL Injection |
Vol. 16 No. 6 |
501 |
Azathioprine 10-mg/mL Injection |
Vol. 16 No. 6 |
502 |
Copper 0.4-mg/mL Injection |
Vol. 16 No. 6 |
503 |
Dipyridamole 5-mg/mL Injection |
Vol. 16 No. 6 |
504 |
Dopamine Hydrochloride 80-mg/mL Injection |
Vol. 16 No. 6 |
505 |
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules |
Vol. 16 No. 6 |
506 |
Papaverine Hydrochloride 30-mg/mL Injection |
Vol. 16 No. 6 |
507 |
Valproate Sodium 100-mg/mL Injection |
Vol. 16 No. 6 |
508 |
Vercuronium Bromide 1-mg/mL Injection |
Vol. 16 No. 6 |
509 |
Stability of Ursodiol in SyrSpend SF Cherry Flavored |
Vol. 16 No. 6 |
510 |
Stability of Propranolol Hydrochloride in SyrSpend SF |
Vol. 16 No. 6 |
513 |
Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations |
Vol. 16 No. 6 |
516 |
PostScription: Center for Compounding Practice and Research Underway at Virginia Commonwealth University School of Pharmacy |
Vol. 16 No. 6 |
524 |